Edgewise Therapeutics Inc
NASDAQ:EWTX
Edgewise Therapeutics Inc
NASDAQ:EWTX
Price:
32.5
USD
-1.01%
Market Cap:
$3.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
US |
|
LSL Property Services PLC
LSE:LSL
|
UK |
Multiples-Based Value
The Multiples-Based Value of one
EWTX
stock under the Base Case scenario is
3.64
USD.
Compared to the current market price of 32.5 USD,
Edgewise Therapeutics Inc
is
Overvalued by 89%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EWTX
Multiples-Based Value
Base Case
3.64
USD
Overvaluation 89%
Multiples Across Competitors
EWTX Competitors Multiples
Edgewise Therapeutics Inc Competitors
Edgewise Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
3.5B USD | 0 | -20.6 | -15.4 | -15.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.4 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP | 5.3 | 30.7 | 17 | 23.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
